| Literature DB >> 30049290 |
Jorge Mata-Garrido1, Olga Tapia1, Iñigo Casafont1, Maria T Berciano1,2, Ana Cuadrado3, Miguel Lafarga4,5.
Abstract
Neurons are highly vulnerable to DNA damage induced by genotoxic agents such as topoisomerase activity, oxidative stress, ionizing radiation (IR) and chemotherapeutic drugs. To avert the detrimental effects of DNA lesions in genome stability, transcription and apoptosis, neurons activate robust DNA repair mechanisms. However, defective DNA repair with accumulation of unrepaired DNA are at the basis of brain ageing and several neurodegenerative diseases. Understanding the mechanisms by which neurons tolerate DNA damage accumulation as well as defining the genomic regions that are more vulnerable to DNA damage or refractory to DNA repair and therefore constitute potential targets in neurodegenerative diseases are essential issues in the field. In this work we investigated the nuclear topography and organization together with the genome-wide distribution of unrepaired DNA in rat cortical neurons 15 days upon IR. About 5% of non-irradiated and 55% of irradiated cells accumulate unrepaired DNA within persistent DNA damage foci (PDDF) of chromatin. These PDDF are featured by persistent activation of DNA damage/repair signaling, lack of transcription and localization in repressive nuclear microenvironments. Interestingly, the chromatin insulator CTCF is concentrated at the PDDF boundaries, likely contributing to isolate unrepaired DNA from intact transcriptionally active chromatin. By confining damaged DNA, PDDF would help preserving genomic integrity and preventing the production of aberrant proteins encoded by damaged genes.ChIP-seq analysis of genome-wide γH2AX distribution revealed a number of genomic regions enriched in γH2AX signal in IR-treated cortical neurons. Some of these regions are in close proximity to genes encoding essential proteins for neuronal functions and human neurodegenerative disorders such as epm2a (Lafora disease), serpini1 (familial encephalopathy with neuroserpin inclusion bodies) and il1rpl1 (mental retardation, X-linked 21). Persistent γH2AX signal close to those regions suggests that nearby genes could be either more vulnerable to DNA damage or more refractory to DNA repair.Entities:
Keywords: DNA damage- ionizing radiation- cortical neurons- persistent DNA damage foci- transcription silencing- CTCF- γH2AX genomic distribution; Neurodegenerative diseases
Mesh:
Substances:
Year: 2018 PMID: 30049290 PMCID: PMC6062993 DOI: 10.1186/s40478-018-0573-6
Source DB: PubMed Journal: Acta Neuropathol Commun ISSN: 2051-5960 Impact factor: 7.801
Fig. 1a-c Representative examples of immunolabeling for γH2AX of cortical neurons in a dissociated neuron preparation (a) and cryosections (b, c) counterstained with propidium iodide (PI) from irradiated rat (a, b) and mouse (c) at 15 days post-IR. Note the presence of typical PDDF associated with the nucleolus. d, e Rat cerebral cortex cryosections double immunolabeled for γH2AX and NeuN illustrate the specific localization of PDDF in NeuN-positive neurons at 15 days post-IR. Scale bars: a-c, e, 5 μm; d, 10 μm
Fig. 2a, b Cerebral cortex cryosections double immunolabeled for γH2AX and GFAP (a) or Iba1 (b) showing the absence of PDDF in an astrocyte and a microglial cell from irradiated rats at 15 days post-IR. Some neuronal nuclei of different size counterstained with DAPI contain γH2AX-positive PDDF. c Cerebral cortex cryosection illustrating a ß-galactosidase-positive senescent microglial cell free of γH2AX-positive PDDF at 15 days post-IR. Scale bars: 10 μm
Fig. 3a, b Representative examples of double immunolabeling for γH2AX and 53BP1 in dissociated cortical neurons from non-irradiated (a) and irradiated rats (15d post-IR) (b). Some neurons exhibited a PDDF immunolabeled for γH2AX and 53BP1. Scale bar: 5 μm. c Western blot analysis of γH2AX in parietal cortex lysates from non-irradiated and irradiated rats (n = 3 animals per group). Protein levels of γH2AX were increased upon DNA-damage induced IR. The expression of histone H3 was used as protein loading control, and the fold increase estimated. d Proportion of cortical neurons containing γH2AX-positive PDDF in non-irradiated and irradiated neurons. (***p < 0.001 by Student’s t test). e Mean number of PDDF per nucleus within the PDDF-containing neuronal population. (*p < 0.05 by Student’s t test). f Distribution of PDDF in three nuclear regions: perinucleolar, nuclear periphery and nuclear interior. Approximately 70% of PDDF were spatially associated with the nucleolus in both non-irradiated and irradiated cortical neurons. g-l Double labeling for γH2AX in combination with 53BP1 (g, h), UBF (j), B23 (k) or histone H4K20me3 (l), and for 53BP1 in combination with WRAP53 (i) illustrating the concentration of γH2AX, 53BP1 and WRAP53 in PDDF, and the spatial association of PDDF with the nucleolus (j, k) and with heterochromatin masses (l). g: non-irradiated neuron. h-l: irradiated neurons at 15 days post-IR. Scale bar: 5 μm
Fig. 4a Immunogold electron microscopy for 53BP1 of a typical PDDF (asterisk) in a rat cortical neuron. It is composed of a loosen network of chromatin fibers decorated with gold particles and appears associated with the nucleolus (No) and a heterochromatin mass (Htc). 15 days post-IR. Scale bar: 500 nm Inset: High magnification of 53BP1-immunolabeled chromatin fibers. b In situ electron microscopy transcription assay illustrating the incorporation of 5′-fluorouridine (5’-FU) into nascent RNA after 45 min of the administration of the halogenated nucleotide. Note the absence of 5’-FU incorporation in the PDDF (asterisk) and its incorporation in the transcriptionally active adjacent euchromatin. Rat cortical neuron after 15 days post-IR. Scale bar: 300 nm. c-e Representative example of double immunolabeling for γH2AX and CTCF in an irradiated cortical neuron showing two perinucleolar PDDF. In addition to a diffuse nuclear distribution of CTCF, this insulator protein appears concentrated in numerous microfoci at the periphery of the γH2AX-positive PDDF. 15 days post-IR. Scale bar: 3 μm. f, g Immunogold electron microscopy for the CTCF shows its preferential distribution at the PDDF boundary with euchromatin, although some scattered gold particles appear within the PDDF (asterisk). No: nucleolus. Scale bars: f, 450 nm; g, 250 nm
Fig. 5Genome wide distribution of γH2AX in rat cortical neurons 15d upon IR shows persistent DNA damage in specific genomic regions. a Table shows the number of total reads, uniquely aligned reads and called peaks for control and irradiated (I1 and I2) rat cortical neurons. Venn diagram shows the overlap (at least one nucleotide) between the called peaks defined in the different conditions. b Read density plots and heatmaps show genome-wide γH2AX distribution in the conditions described in a. c UCSC browser images showing γH2AX binding in different genomic regions close to neuronal specific processes and pathologies. d ChIP-qPCR analysis of CTCF enrichment around several γH2AX binding sites defined by ChIP-seq. Immunoprecipitation with rabbit IgG was performed to ensure antibody specificity. Neg1 and neg2 correspond to genomic regions with undetectable γH2AX binding. Pcdh and krt loci were used as positive CTCF binding sites. Graph represents the results of two independent biological replicates performed in triplicates.
γH2AX-binding genomic regions specifically enriched in PDDF from cortical neurons and related to human genes implicated in neurological and neuropsychiatric disorders
| Gene | Encoded protein | Fold change | Relation to human pathology | Reference |
|---|---|---|---|---|
|
| Aspartylglucosaminidase | 2.875 | Aspartylglucosaminuria (0.69) | [ |
|
| Adaptor protein containing Ph domain, Ptb domain and leucine zipper motif 2 | 3.31 | Substance adiction (0.2) | [ |
|
| Cadherin 10 | 2.88 | Autism (0.2) | [ |
|
| Laforin glucan phosphatase | 2.25 | Lafora disease (0.71), progressive myoclonus epilepsy (0.407) | [ |
|
| F-box/WD repeat containing protein 7 | 2.25 | Glioma (0.127), genome instability (0.12) | [ |
|
| Glutamate receptor 1 | 3.72 | Schizophrenia (0.208), Bipolar Disorder (0.206), Mental Depression and Depressive disorder (0.201), learning and memory disorders (0.2) | [ |
|
| Glutamate receptor 1 | 2.69 | Schizophrenia (0.209), Bipolar Disorder (0.203), Depressive disorder (0.201) | [ |
|
| Serotonin 5-Ht-1A receptor 1A | 2.72 | Mental Depression and Depressive disorder (0.253), Schizophrenia (0.221) | [ |
|
| Interleukin 1-β | 2.39 | Alzheimer disease (0.369) | [ |
|
| Interleukin 1 receptor accessory protein-like 1 | 2.375 | Autism (0.404), Mental retardation (0.205) | [ |
|
| Lamin b receptor | 2.39 | Reynold syndrome (0.6) | [ |
|
| Ras-related protein Rab-38 | 3.38 | Frontotemporal dementia (0.12) | [ |
|
| Sodium channel protein type 4 subunit alpha | 3.19 | Hyperkalemic periodic paralysis (0.688), Potassium-aggravated myotonia (0.602), Hypokalemic periodic paralysis type 2 (0.48), Hypokalemic periodic paralysis type 1 (0.41), Congenital paramyotonia (0.408), Fluctuating myotonia (0.24), Myotonia (0.405) | [ |
|
| Neuroserpin | 2.88 | Familial encephalopathy with neuroserpin inclusion bodies (0.681), Dementia (0.208), Progressive myoclonus epilepsy (0.203) | [ |
|
| Succinyl-CoA; Glutarate-CoA transferase | 3.71 | Migraine (0.24) | [ |
|
| Transketolase | 2.23 | Wernicke-Korsakoff syndrome, Wernicke encephalopaty (0.201) | [ |
The number in brackets that appears next to the name of diseases corresponds to the “Score of the reliability of the gene-disease pair, based on the type and number of sources where is reported, and the number of PMIDs”